ASCO: Endocrine Tx Noninferior for HR + , HER2 − Breast Cancer
Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21 - gene recurrence score
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Pharmacy, Conference News, Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Conferences | Genetics | HER2 | Pathology | Women